Author: Capucine Lepicard

From October 3–5, 2025, the LaTIM team represented by Mostafa El Habib Daho & Gwenolé Quellec participated in the Fête de la Science at the “Musée des Arts et Métiers” in Paris, to showcase our groundbreaking work within the EviRed project.

We were thrilled to present our latest advancements in AI for retinal imaging and diabetic retinopathy management to the public. The insightful and thought-provoking questions from visitors highlighted the immense curiosity and enthusiasm for science and medical innovation.

A heartfelt thank you to everyone who visited our booth and engaged in such enriching discussions!

We were delighted to attend the exciting and rewarding EURETINA 2025 meeting in Paris, held from September 4–7.

The congress was filled with informative presentations, inspiring conversations, and valuable exchanges from across the world.

The EviRed team was proudly represented with several scientific contributions:

• Pascale Massin (top of the photo) presented the baseline data of the EviRed (Evaluation Intelligente de la Rétinopathie Diabétique) cohort.
• Carla Danese (left of the photo) shared her study on “The effect of new antidiabetic drugs on one-year change of OCT-A metrics.”
• Patrizio Bernardinelli (not in the photo) presented an e-poster: “Comparative Analysis of Optos and Clarus Devices in Neovascularization and Diabetic Retinopathy Grading in the EviRed Study.”
• Abir Zureik (right of the photo) presented an e-poster: “Evolution of ophthalmological care in adults with diabetes in France between 2010 and 2022: a nationwide study.”

This strong representation highlights the richness and diversity of the EviRed project.

The conference addressed the retinal diseases from multiple perspectives: medical, imaging, clinical research, treatments, surgery; and above all, questioning and discussing the rising role of artificial intelligence in this field.

Such a diverse scope enabled enriched discussions and broadened our vision of future innovations.

We return from Euretina2025 inspired, motivated, and already looking forward to next year’s meeting!

This year, the Maculart International Meeting took place in Paris from June 29th to July 1st.

The scientific program was rich and focused on retinal pathologies, including diabetic maculopathy, advances in imaging, and the integration of artificial intelligence in ophthalmology.

Dr. Patrizio Bernardinelli presented his study: “EVIRED Study: Comparative Performance of Optos and Clarus UWF Imaging for neovascularization Detection and DR Severity.” (cf. photo in the middle)

Mrs. Abir Zureik presented her study: “Evolution of Ophthalmological Care in Adults with Diabetes in France Between 2010 and 2022: A Nationwide Study.” (cf. photo on the top; on the left Mrs. Abir Zureik, on the right Pr. Aude Couturier)

The meeting brought together the world’s leading experts in macular diseases, fostering an environment of innovation and excellence.
We had the opportunity to attend insightful presentations by EVIRED SAB members Dr. Pearce Keane and Dr. Nadia Waheed. As always, Dr. Richard Spaide’s lecture on “FOVEATION” was particularly enlightening.

The principal investigators of the EVIRED study were also present. It was a valuable opportunity to learn from the contributions of Dr. Catherine Creuzot-Garcher, Dr. Laurent Kodjikian, Dr. Jean-François Korobelnik, and Dr. Alexandra Miere.
Finally, Prof. Aude Couturier provided a brief overview of the progress of the EVIRED project and the ongoing clinical study.

Looking forward to the next meeting!

We are thrilled to announce that EviRed’s new videos are now available! 🎥

• Want to learn more about EviRed programm?

The « JT de l’ophtalmologie » interview from EviRed’s team members , provides information about the mission, goals, challenges and next steps for EviRed . Listen  to Pr Aude Couturier, Capucine Lepicard, Dr Sophie Bonnin, and Gwenole Quellec tell you more.

• Want to learn about EvIred cohort included ?.

Don’t miss the  interview ( in French)  with Pr Pascale Massin, who provides insights into the EviRed cohort design and description. presents the first trends observed in the cohort.

Click :Here

Stay tuned for more updates !

The French ophthalmology community had 2 importants events in the last 2 weeks :

• First of all, some members of EviRed team attended the Association for Research in Vision and Ophthalmology (ARVO) 2025 conference, held in Salt Lake City, Utah, from May 4th to 8th. This conference brings annually together the ophthalmology research community.

Mostafa El Habib Daho presented a very interesting poster entitled « Device-Agnostic Deep Learning Framework for Diabetic Retinopathy Grading Using Ultra-Widefield Fundus Photography ».

And Carla Danese presented a poster related to « the effect of a new antidiabetic drugs on one-year change of OCT-A metrics, work performed on EviRed data ».

• Then, some EviRed team members  attended the SFO 2025 (annual meeting of the French Ophthalmology Society) in Paris from May 10th to 12th.

EviRed was highlighted, as examples,

• During a passionated 2h session organized by SFO titled « IA from today to tomorrow in ophthalmology » where the Evired Partners were well represented by Prof. Beatrice Cochener from the LaTIM, Prof. Aude Couturier from AP-HP and Stéphanie Magazzeni from ZEISS as key speakers.
• During a retina-dedicated session, Prof. Pascale Massin presented a description of the population included in EviRed cohort.

Those meetings are always a good moment to exchange and meet with our partners.

On the pictures :

• On the top, during ARVO 2025 (from left to right and from the top to the bottom)
  • C. Danese
  • D. Cosette, M. Lamard, A. Couturier, M. El Habib Daho, S. Gate, I. Raden, S. Magazzeni, A. Saheli
  • S. Bonnin, D. Cosette, M. El Hadi Daho
  • M. Lamard, A.Couturier , M. El Habib Daho , S. Bonnin, F. Potevin et J. Abou Assi
• During the SFO 2025
  • From the top to bottom, and from left to right : L. Foulon-Pinto, S. Bonnin, Q. Bougault, M. Hemmendinger ,P. Massin, A. Couturier, C. Lepicard, T Hamlat, R. Ben Othman
  • On the right, P Massin during the retina-dedicated session
  • On the left, B. Cochener during the AI conference